The effect of PN-1, a Traditional Chinese Prescription, on the Learning and Memory in a Transgenic Mouse Model of Alzheimer’s Disease

Abstract EN

Traditional Chinese Medicine (TCM) is a complete medical system that has been practiced for more than 3000 years.

Prescription number 1 (PN-1) consists of several Chinese medicines and is designed according to TCM theories to treat patients with neuropsychiatric disorders.

The evidence of clinical practice suggests the benefit effects of PN-1 on cognitive deficits of dementia patients.

We try to prove and explain this by using contemporary methodology and transgenic animal models of Alzheimer’s disease (AD).

The behavioral studies were developed to evaluate the memory of transgenic animals after intragastric administration of PN-1 for 3 months.

Amyloid beta-protein (Aβ) neuropathology was quantified using immunohistochemistry and ELISA.

The western blotting was used to detect the levels of plasticity associated proteins.

The safety of PN-1 on mice was also assessed through multiple parameters.

Results showed that PN-1 could effectively relieve learning and memory impairment of transgenic animals.

Possible mechanisms showed that PN-1 could significantly reduce plaque burden and Aβ levels and boost synaptic plasticity.

Our observations showed that PN-1 could improve learning and memory ability through multiple mechanisms without detectable side effects on mice.

We propose that PN-1 is a promising alternative treatment for AD in the future.